Leader sequences for directing secretion of polypeptides and methods for production thereof

Details for Australian Patent Application No. 2006207999 (hide)

Owner Five Prime Therapeutics, Inc.

Inventors Bosch, Elizabeth; Lee, Ernestine; Halenbeck, Robert Forgan; Linnemann, Thomas

Agent Pizzeys

Pub. Number AU-A-2006207999

PCT Pub. Number WO2006/081430

Priority 60/647,013 27.01.05 US

Filing date 27 January 2006

Wipo publication date 3 August 2006

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/081430 Priority application(s): WO2006/081430

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208012-Treatment of metastasized tumors

2006207998-A method for characterizing the efficacy of an agent targeting a primary cystic fibrosis defect